Cargando…

Star-Shaped Intense Uptake of (131)I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq

BACKGROUND: After initial radioactive iodine (RAI) treatment in differentiated thyroid cancer patients, we sometimes observe a star-shaped region of intense uptake of (131)I on whole body scans (WBSs), called a ‘star artifact.’ We evaluated the clinical implications of star artifacts on the success...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Sung Hye, Lim, Jung Ah, Song, Young Shin, Moon, Shinje, Kim, Ye An, Kim, Min Joo, Cho, Sun Wook, Moon, Jae Hoon, Yi, Ka Hee, Park, Do Joon, Cho, Bo Youn, Park, Young Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021303/ https://www.ncbi.nlm.nih.gov/pubmed/29766683 http://dx.doi.org/10.3803/EnM.2018.33.2.228

Ejemplares similares

Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
por: Kim, Min Joo, et al.
Publicado: (2022)

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative (131)I Administration: A Real Life Study
por: Campennì, Alfredo, et al.
Publicado: (2023)

The Impact of Low Adherence to the Low-iodine Diet on the Efficacy of the Radioactive Iodine Ablation Therapy
por: Ju, Dal Lae, et al.
Publicado: (2015)

Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
por: Al Aamri, Marwa, et al.
Publicado: (2016)

Risk of Adverse Pregnancy Outcomes in Young Women with Thyroid Cancer: A Systematic Review and Meta-Analysis
por: Moon, Shinje, et al.
Publicado: (2022)

Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region
por: Ju, Dal Lae, et al.
Publicado: (2016)

Outcomes of Radioactive Iodine ((131)I) Therapy among Hyperthyroid patients
por: Khan, Muhammad Sajjad Ali, et al.
Publicado: (2023)

Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer
por: Iwano, Shingo, et al.
Publicado: (2020)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose
por: Wong, Ka Kit, et al.
Publicado: (2018)

A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
por: Lee, Eun Kyung, et al.
Publicado: (2020)

Knowledge, Self-Efficacy, and Perceived Barriers on the Low-Iodine Diet among Thyroid Cancer Patients Preparing for Radioactive Iodine Therapy
por: Moon, Jeong-Ah, et al.
Publicado: (2012)

Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
por: Mortazavi, Seyed Mohammad Javad, et al.
Publicado: (2023)

Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level
por: Yartsev, Vasily D, et al.
Publicado: (2023)

Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis
por: Min, Se Hee, et al.
Publicado: (2015)

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
por: Sundaram, P. Shanmuga, et al.
Publicado: (2011)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Normal Gallbladder Visualization during Post-Ablative Iodine-131 Scan of Thyroid Cancer
por: Seok, Ju-Won, et al.
Publicado: (2005)

Chylothorax Associated with Substernal Goiter in Graves’ Disease Treated with Radioactive Iodine
por: Young Oh, Seo, et al.
Publicado: (2017)

Risk Factors for Developing Hyponatremia in Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy
por: Lee, Jung Eun, et al.
Publicado: (2014)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Drug-induced liver injury caused by iodine-131
por: Kim, Chei Won, et al.
Publicado: (2016)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

Incidence of Hypothyreoidism after Radioactive Iodine–I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose
por: Beslic, Nermina, et al.
Publicado: (2017)

Efficacy of a Graphene Oxide/Chitosan Sponge for Removal of Radioactive Iodine-131 from Aqueous Solutions
por: Suksompong, Tanate, et al.
Publicado: (2021)

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
por: Lee, Chang-Hee, et al.
Publicado: (2018)

Comparison of Prevalence and Ultrasonography Features of Thyroglossal Duct Cyst in Adults According to Radioactive Iodine Ablation
por: Lee, Yoo Jin, et al.
Publicado: (2019)

Multi-GBq production of the radiotracer [(18)F]fallypride in a droplet microreactor
por: Wang, Jia, et al.
Publicado: (2020)

Relationship of iodine excess with thyroid function in 6-year-old children living in an iodine-replete area
por: Lee, Yun Jeong, et al.
Publicado: (2023)

Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients
por: Kim, Jahae, et al.
Publicado: (2017)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
por: Oh, Ji Min, et al.
Publicado: (2022)

Iodine Uptake in Retroperitoneal Cysts after Radioactive Iodine Treatment
por: Lee, Ji Young, et al.
Publicado: (2020)

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)

Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases
por: Al-Qahtani, Khalid Hussain, et al.
Publicado: (2014)

Preparation and Characterization of Hyaluronic Acid-Polycaprolactone Copolymer Micelles for the Drug Delivery of Radioactive Iodine-131 Labeled Lipiodol
por: Chen, Shih-Cheng, et al.
Publicado: (2017)

(131)I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine
por: Brudecki, K., et al.
Publicado: (2020)

Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
por: Iizuka, Yusuke, et al.
Publicado: (2023)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Prevalence and Features of Thyroglossal Duct Cyst on Ultrasonography, According to Radioactive Iodine Therapy: A Single-Center Study
por: Park, Ji Sun, et al.
Publicado: (2020)

A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases
por: Kanankulam Velliangiri, Sivasankar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_20l05pn9pjbb6ef6u0ju3vi63p